Latest Articles

Publication Date
Aspira Women’s Health Advances Endometriosis Diagnosis with EndoCheck Study - TipRanks

Aspira Women’s Health Advances Endometriosis Diagnosis with EndoCheck Study TipRanks

Published: Oct. 27, 2025, 6:47 p.m.
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - TipRanks

Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment TipRanks

Published: Oct. 27, 2025, 6:32 p.m.
Seek medical help for menstrual pain: 13th Asian Endometriosis Congress to be held in Colombo - Daily Mirror - Sri Lanka

Seek medical help for menstrual pain: 13th Asian Endometriosis Congress to be held in Colombo Daily Mirror - Sri Lanka

Published: Oct. 27, 2025, 6:30 p.m.
Seek medical help for menstrual pain: 13th Asian Endometriosis Congress to be held in Colombo - dailymirror.lk

Seek medical help for menstrual pain: 13th Asian Endometriosis Congress to be held in Colombo dailymirror.lk

Published: Oct. 27, 2025, 6:30 p.m.
Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment - TipRanks

Hutchmed’s Promising Phase III Study on Advanced Endometrial Cancer Treatment TipRanks

Published: Oct. 27, 2025, 5:04 p.m.
NatureNova personal water filter straw deal: $10.38 - Mashable

NatureNova personal water filter straw deal: $10.38 Mashable

Published: Oct. 27, 2025, 4:27 p.m.
Curcumol alleviates endometriosis via correcting the aberrant activation of Fas/RIPK1-mediated PANoptosis - Frontiers

Curcumol alleviates endometriosis via correcting the aberrant activation of Fas/RIPK1-mediated PANoptosis Frontiers

Published: Oct. 27, 2025, 4:10 p.m.
Diagnostic role of galanin in distinguishing endometrial atypical hyperplasia and carcinoma from benign endometrial conditions - Nature

Diagnostic role of galanin in distinguishing endometrial atypical hyperplasia and carcinoma from benign endometrial conditions Nature

Published: Oct. 27, 2025, 2:48 p.m.
Pearsanta (NASDAQ: ADTX) begins study of endometriosis blood test, up to 1,000 participants - Stock Titan

Pearsanta (NASDAQ: ADTX) begins study of endometriosis blood test, up to 1,000 participants Stock Titan

Published: Oct. 27, 2025, 12:30 p.m.
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers - The Manila Times

Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers The Manila Times

Published: Oct. 27, 2025, 12:17 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!